SCHEMBL8501237

SCHEMBL8501237

CCCCc1c(N2CC(NC(=O)c3ccccc3)C2)ccc2c1C(C(=O)NCC(F)(F)F)c1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTTP P55157 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ DRD2 P14416 4/20 0.35
▸ DRD4 P21917 4/20 0.35
▸ DRD3 P35462 3/20 0.35
▸ CHRM1 P11229 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ NAAA Q02083 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501050 0.98 MTTP (0.36) MTTPPOLBDRD2DRD4DRD3
SCHEMBL8665881 0.94 DRD2 (0.37) MTTPPOLBDRD2DRD4DRD3
SCHEMBL8666097 0.92 DRD2 (0.36) MTTPPOLBDRD2DRD4DRD3
SCHEMBL8502239 0.91 DRD2 (0.39) DRD2DRD4DRD3CHRM1HPGD
SCHEMBL8500999 0.90 CTSL (0.37) POLBDRD2DRD4DRD3PSEN1
SCHEMBL8500944 0.86 MCHR1 (0.34) MTTPDRD2DRD4CHRM1GABRA5
SCHEMBL8593680 0.85 POLB (0.42) POLBDRD2DRD4DRD3PSEN1
SCHEMBL8669688 0.85 DRD2 (0.39) DRD2DRD4DRD3CHRM1NPSR1
SCHEMBL8714745 0.84 CHRM1 (0.41) DRD2DRD4DRD3CHRM1HPGD
SCHEMBL8665490 0.84 FPR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US claimed
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US disclosed
Send feedback